Methoden / Methods inc. ICCC-3 105
|
|
|
- Theodore Sparks
- 5 years ago
- Views:
Transcription
1 Methoden / Methods inc. ICCC Internationale Klassifikation der Krebserkrankungen bei Kindern (ICCC-3) Zuordnung von ICD-O-3-Codes für Morphologie und Topographie zu diagnostischen Kategorien International Classification of Childhood Cancer (ICCC-3) Categorization of morphology and topography codes, corresponding to ICD-O-3 adapted from: Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, Third Edition. Cancer 103, , I LEUKAEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES (a) Lymphoid leukaemias 9820, 9823, 9826, 9827, , 9940, Precursor cell leukaemias 9835, 9836, Mature B-cell leukaemias 9823, 9826, 9832, 9833, Mature T-cell and NK cell leukaemias 9827, 9831, 9834, Lymphoid leukaemia, NOS 9820 (b) Acute myeloid leukaemias 9840, 9861, 9866, 9867, , 9891, , 9910, 9920, 9931 (c) Chronic myeloproliferative diseases 9863, 9875, 9876, 9950, (d) Myelodysplastic syndrome and other myeloproliferative diseases 9945, 9946, 9975, 9980, , 9989 (e) Unspecified and other specified leukaemias 9800, 9801, 9805, 9860, 9930 II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS (a) Hodgkin lymphomas , 9659, , 9667 (b) Non-Hodgkin lymphomas (except Burkitt lymphoma) 9591, 9670, 9671, 9673, 9675, , 9684, , 9695, , 9705, 9708, 9709, 9714, , , , , , Precursor cell lymphomas 9727, 9728, Mature B-cell lymphomas (except Burkitt lymphoma) # 9670, 9671, 9673, 9675, , 9684, , 9695, 9698, 9699, , 9761, 9762, , 9769, Mature T-cell and NK-cell lymphomas , 9705, 9708, 9709, 9714, , 9767, Non-Hodgkin lymphomas, NOS 9591, 9760 (c) Burkitt lymphoma 9687 (d) Miscellaneous lymphoreticular neoplasms , 9750, (e) Unspecified lymphomas 9590, 9596 # Burkitt lymphoma (IIc), as a mature B-cell non-hodgkin lymphoma, may be pooled with IIb2 for overall presentation of B-cell lymphomas T-cell lymphoma, NOS in a child almost always corresponds to code M-9729.
2 106 Methoden / Methods inc. ICCC-3 III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS (a) Ependymomas and choroid plexus tumour 9383, Ependymomas 9383, Choroid plexus tumour 9390 (b) Astrocytomas , , 9420, , (c) Intracranial and intraspinal embryonal tumours , 9480, C72.3 C70.0-C Medulloblastomas , 9474, Primitive neuroectodermal tumour (PNET) Medulloepithelioma Atypical teratoid / rhabdoid tumour 9508 (d) Other gliomas , 9382, 9430, 9444, 9450, 9451, Oligodendrogliomas 9450, 9451, Mixed and unspecified gliomas Neuroepithelial glial tumours of uncertain origin 9381, 9430, 9444 C70.0-C72.9 C70.0-C72.2, C72.4-C72.9, C75.1, C75.3 C70.0-C72.2, C72.4-C72.9, C75.1, C75.3 (e) Other specified intracranial and intraspinal neoplasms , 8300, , , 9412, 9413, 9492, 9493, , , Pituitary adenomas and carcinomas , Tumours of the sellar region (craniopharyngiomas) , Pineal parenchymal tumours Neuronal and mixed neuronal-glial tumours 5 Meningiomas , 9413, 9492, 9493, (f) Unspecified intracranial and intraspinal neoplasms C70.0-C72.9, C75.1-C75.3 Tumours with non-malignant behaviour codes are included
3 Methoden / Methods inc. ICCC IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMOURS (a) Neuroblastoma and ganglioneuroblastoma 9490, 9500 (b) Other peripheral nervous cell tumours , , 8700, C00.0-C69.9, C73.9-C76.8, V RETINOBLASTOMA VI RENAL TUMOURS (a) Nephroblastoma and other non-epithelial renal tumours 8959, 8960, , 9364 C Nephroblastoma 8959, Rhabdoid renal tumour 8963 C Kidney sarcomas Peripheral neuroectodermal tumour (ppnet) of kidney 9364 C64.9 (b) Renal carcinomas , , 8082, , , 8143, 8155, , 8210, 8211, , 8240, 8241, , , 8290, 8310, 8320, 8323, 8401, 8430, 8440, , 8504, 8510, 8550, , 8312, , 8361 C64.9 (c) Unspecified malignant renal tumours C64.9 VII HEPATIC TUMOURS (a) Hepatoblastoma 8970 (b) Hepatic carcinomas , , 8082, , 8140, 8141, 8143, 8155, , 8210, 8211, 8230, 8231, 8240, 8241, , , 8310, 8320, 8323, 8401, 8430, 8440, , 8504, 8510, 8550, C22.0, C22.1 (c) Unspecified malignant hepatic tumours C22.0, C22.1
4 108 Methoden / Methods inc. ICCC-3 VIII MALIGNANT BONE TUMOURS (a) Osteosarcomas , , 9200 (b) Chondrosarcomas 9210, 9220, 9240 C40.0-C41.9, C40.0-C41.9, 9221, 9230, (c) Ewing tumour and related sarcomas of bone 9260 C40.0-C41.9, C40.0-C Ewing tumour and Askin tumour of bone 9260 C40.0-C41.9, 9365 C40.0-C Peripheral neuroectodermal tumour (ppnet) of bone 9363, 9364 C40.0-C41.9 (d) Other specified malignant bone tumours 8810, 8811, 8823, 8830 C40.0-C , 9250, 9261, 9262, , , 9290, , , , 9330, , Malignant fibrous neoplasms of bone 8810, 8811, 8823, 8830 C40.0-C , Malignant chordomas Odontogenic malignant tumours , , 9290, , , , 9330, Miscellaneous malignant bone tumours 9250, 9261 (e) Unspecified malignant bone tumours , 8800, 8801, C40.0-C41.9 IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS (a) Rhabdomyosarcomas , 8910, 8912, 8920, 8991 (b) Fibrosarcomas, peripheral nerve sheath tumours and other fibrous neoplasms 1 Fibroblastic and myofibroblastic tumours 8810, 8811, , 8821, 8823, , 8822, , 9150, 9160, 9491, , , 8811, , 8821, 8823, , 8822, , 9150, 9160 C44.0-C76.8, C44.0-C76.8, 2 Nerve sheath tumours Other fibrous neoplasms 9491, 9580
5 Methoden / Methods inc. ICCC IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS (cont.) (c) Kaposi sarcoma 9140 (d) Other specified soft tissue sarcomas 8587, , 8806, , 8836, , , , 8870, 8880, 8881, , 8921, 8982, 8990, , , , 9135, 9136, 9141, 9142, 9161, , 9231, 9251, 9252, 9373, C44.0-C76.8, C00.0-C63.9, C73.9-C76.8, 9180, 9210, 9220, 9240 C49.0-C Ewing tumour and Askin tumour of soft tissue Peripheral neuroectodermal tumour (ppnet) of soft tissue Extrarenal rhabdoid tumour 8963 C47.0-C75.9 C47.0-C63.9, C73.9-C76.8, C47.0-C63.9, C65.9-C76.8, C47.0-C75.9 C47.0-C63.9, C65.9-C76.8, 80.9 C47.0-C63.9, C73.9-C76.8, 80.9 C00.0-C63.9, C73.9-C76.8, Liposarcomas , , 8870, 8880, Fibrohistiocytic tumours 8830 C44.0-C76.8, , 8836, 9251, Leiomyosarcomas Synovial sarcomas Blood vessel tumours , , 9135, 9136, 9141, 9142, 9161, Osseous and chondromatous neoplasms of soft tissue 9180, 9210, 9220, 9240 C49.0-C Alveolar soft parts sarcoma Miscellaneous soft tissue sarcomas 8587, , 8806, , 8921, 8982, 8990, 9373
6 110 Methoden / Methods inc. ICCC-3 IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS (cont.) (e) Unspecified soft tissue sarcomas C44.0-C76.8, X GERM CELL TUMOURS, TROPHOBLASTIC TUMOURS AND NEOPLASMS OF GONADS (a) Intracranial and intraspinal germ cell tumours , , , 9100, 9101 C70.0-C72.9, C75.1-C Intracranial and intraspinal germinomas Intracranial and intraspinal teratomas Intracranial and intraspinal embryonal carcinomas 9070, Intracranial and intraspinal yolk sac tumour Intracranial and intraspinal choriocarcinoma Intracranial and intraspinal tumours of mixed forms 9085, 9101 C70.0-C72.9, C75.1-C75.3 (b) Malignant extracranial and extragonadal germ cell tumours , , , C00.0-C55.9, C63.0-C69.9, C73.9-C75.0, C75.4-C76.8, Malignant germinomas of extracranial and extragonadal sites Malignant teratomas of extracranial and extragonadal sites Embryonal carcinomas of extracranial and extragonadal sites 4 Yolk sac tumour of extracranial and extragonadal sites , 9072 C00.0-C55.9, C63.0-C69.9, C73.9-C75.0, C75.4-C76.8, Choriocarcinomas of extracranial and extragonadal sites 9100, 9103, Other and unspecified malignant mixed germ cell tumours of extracranial and extragonadal sites (c) Malignant gonadal germ cell tumours 9085, 9101, 9102, , , , 9090, 9091, 9100, 9101 C56.9, C62.0-C Malignant gonadal germinomas Malignant gonadal teratomas , 9090, Gonadal embryonal carcinomas 9070, Gonadal yolk sac tumour Gonadal choriocarcinoma 9100 C56.9, C62.0-C Malignant gonadal tumours of mixed forms 9085, Malignant gonadal gonadoblastoma 9073 Tumours with non-malignant behaviour codes are included
7 Methoden / Methods inc. ICCC X GERM CELL TUMOURS, TROPHOBLASTIC TUMOURS AND NEOPLASMS OF GONADS (cont.) (d) Gonadal carcinomas , , 8082, , , 8143, , 8210, 8211, , , , 8290, 8310, 8313, 8320, 8323, , 8430, 8440, , 8504, 8510, 8550, , 9000, 9014, , 8450, 8451, C56.9, C62.0-C62.9 (e) Other and unspecified malignant gonadal tumours C56.9, C62.0-C62.9 XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS (a) Adrenocortical carcinomas (b) Thyroid carcinomas , , 8082, , , 8190, 8200, 8201, 8211, 8230, 8231, , , 8290, 8310, 8320, 8323, 8430, 8440, 8480, 8481, 8510, , , 8350 C73.9 (c) Nasopharyngeal carcinomas , , 8082, 8083, , , 8190, 8200, 8201, 8211, 8230, 8231, , , 8290, 8310, 8320, 8323, 8430, 8440, 8480, 8481, C11.0-C11.9 (d) Malignant melanomas , 8790 (e) Skin carcinomas , , 8078, 8082, , 8140, 8143, 8147, 8190, 8200, 8240, 8246, 8247, 8260, 8310, 8320, 8323, , 8430, 8480, 8542, 8560, , 8940, 8941 C44.0-C44.9 (f) Other and unspecified carcinomas , , , 8290, 8310, , , 8360, , , , , , 8940, 8941, 8983, 9000, , 9020, 9030 C00.0-C10.9, C12.9-C21.8, C23.9-C39.9, C48.0-C48.8, C50.0-C55.9, C63.0-C63.9, C65.9-C72.9, C75.0-C76.8, 1 Carcinomas of salivary glands C07.9-C08.9 C18.0, 2 Carcinomas of colon and rectum , , , 8290, 8310, , , 8360, , , , , , 8940, 8941, 8983, C18.2-C18.9, C19.9, C20.9, C21.0-C , , 9020, Carcinomas of appendix C Carcinomas of lung C34.0-C34.9
8 112 Methoden / Methods inc. ICCC-3 XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS (cont.) (f) Other and unspecified carcinomas (cont.) 5 Carcinomas of thymus C Carcinomas of breast C50.0-C Carcinomas of cervix uteri C53.0-C Carcinomas of bladder C67.0-C Carcinomas of eye C69.0-C Carcinomas of other specified sites 11 Carcinomas of unspecified site , , , 8290, 8310, , , 8360, , , , , , 8940, 8941, 8983, 9000, , 9020, 9030 C00.0-C06.9, C09.0-C10.9, C12.9-C17.9, C23.9-C33.9, C38.0-C39.9, C48.0-C48.8, C51.0-C52.9, C54.0-C54.9, C55.9, C63.0-C63.9, C65.9-C66.9, C68.0-C68.9, C70.0-C72.9, C75.0-C75.9 XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS (a) Other specified malignant tumours , 8950, 8951, , , C47.0-C Gastrointestinal stromal tumour Pancreatoblastoma Pulmonary blastoma and pleuropulmonary blastoma 8972, Other complex mixed and stromal neoplasms , 8950, 8951, Mesothelioma Other specified malignant tumours (b) Other unspecified malignant tumours C47.0-C75.9 C00.0-C21.8, C23.9-C39.9, C42.0-C55.9, C63.0-C63.9, C73.9-C75.0, C75.4-
Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group)
Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group) January 2013 The NCIN is a UK-wide initiative, working to drive improvements in standards of cancer care and clinical outcomes by improving
Pediatric Cancer in Idaho,
Pediatric Cancer in Idaho, 1996-2006 Although relatively rare in comparison with cancer in older adults, cancer is the second leading cause of death in persons aged 1-14 years. The epidemiology of cancer
Childhood cancer registration in England: 2015 to 2016
Childhood cancer registration in England: 2015 to 2016 Report on behalf of the Children, Teenagers and Young Adults Site Specific Clinical Reference Group, National Cancer Registration and Analysis Service
PEDIATRIC CANCER IN IDAHO
PEDIATRIC CANCER IN IDAHO 2001-2010 May 2013 A Publication of the ACKNOWLEDGMENTS The Idaho Hospital Association (IHA) contracts with, and receives funding from, the Idaho Department of Health and Welfare,
PEDIATRIC CANCER IN IDAHO
PEDIATRIC CANCER IN IDAHO 1999-2008 May 2011 A Publication of the ACKNOWLEDGMENTS The Idaho Hospital Association (IHA) contracts with, and receives funding from, the Idaho Department of Health and Welfare,
CLIC Sargent Eligibility Criteria
1 Eligibility Criteria DOCUMENT GOVERNANCE: Eligibility criteria Produced by J. Hawkins & Grants Team Sponsored by Dara de Burca Version Approval by Executive Team 10 th June 2014 Board of Trustees 3 rd
Childhood Cancer Statistics, England Annual report 2018
Childhood Cancer Statistics, England Annual report 2018 Report on behalf of the Children, Teenagers and Young Adults Expert Advisory Group, National Cancer Registration and Analysis Service 1 About Public
EPIDEMIOLOGICAL REVIEW CANCERS AMONG CHILDREN AND ADOLESCENTS AT A CANCER HOSPITAL IN PAKISTAN
EPIDEMIOLOGICAL REVIEW CANCERS AMONG CHILDREN AND ADOLESCENTS AT A CANCER HOSPITAL IN PAKISTAN Farhana Badar, Shahid Mahmood Cancer Registry and Clinical Data Management, Shaukat Khanum Memorial Cancer
Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER
Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER Table 1.1 gives the total number of cancers diagnosed at five different hospital based cancer registries (HBCRs), over the period of two years from 1st January
PEDIATRIC CANCER IN IDAHO
PEDIATRIC CANCER IN IDAHO 2006-2015 A Publication of the ACKNOWLEDGMENTS The Idaho Hospital Association (IHA) contracts with, and receives funding from, the Idaho Department of Health and Welfare, Division
The International Classification of Diseases for Oncology (ICD-O) is
1425 COMMENTARY Classification Schemes for Tumors Diagnosed in Adolescents and Young Adults Ronald D. Barr, M.B., Ch.B., M.D. 1 3 Eric J. Holowaty, M.D., M.Sc. 4 Jillian M. Birch, B.Sc., M.Sc., Ph.D. 5
Acknowledgements and Disclaimer
Infant Cancers in California, 1988 2011 Acknowledgements and Disclaimer The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of
incidence rate x 100,000/year
Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European
Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository ( ) for cancer in Teenagers and Young Adults
Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository (2007 09) for cancer in Teenagers and Young Adults (TYA) CTYA SSCRG Data quality report on the frequency
Childhood Cancer Report on Cancer Statistics in Alberta. December Cancer Care. Cancer Surveillance
December 12 1 Report on Cancer Statistics in Alberta Acknowledgements 2 This report was made possible through Alberta Health Services,, and the many contributions of staff and management across Alberta
Cancer Incidence in Belgium
Cancer Incidence in Belgium 2010 Special issue Cancer in Children and Adolescents Belgian Cancer Registry Cancer Incidence in Belgium 2010 Special issue Cancer in Children and Adolescents Belgian Cancer
Childhood cancer incidence in Australia, Published December 2009
Childhood cancer incidence in Australia, 1983 2006 Published December 2009 Postal Address: 553 Gregory Terrace PO Box 201 Fortitude Valley QUEENSLAND 4006 Spring Hill QUEENSLAND 4004 AUSTRALIA AUSTRALIA
13-24 year olds with cancer in England Incidence, mortality and survival
13-24 year olds with cancer in England Incidence, mortality and survival National Cancer Registration and Analysis Service in collaboration with Teenage Cancer Trust About Public Health England Public
National Registry of Childhood Tumours Progress Report, 2010
National Registry of Childhood Tumours Progress Report, 21 The material which follows constitutes the first of a series of reports produced by the National Registry of Childhood Tumours (NRCT) for the
Mohamed Agha, PhD Madeline Riehl, MHSc
Photo by Tynan Studio Jason D. Pole, PhD Mark L. Greenberg, OC, MB, ChB, FRCPC Lillian Sung, MD, PhD, FRCPC 48 Mohamed Agha, PhD Madeline Riehl, MHSc Atlas of Childhood Cancer in Ontario (1985-2004) Chapter
Pattern of deaths in the year following diagnosis in cancer patients aged years in England. Children and Young Adults CRG
Pattern of deaths in the year following diagnosis in cancer patients aged 15-24 years in England Children and Young Adults CRG Pattern of deaths in the year following diagnosis in cancer patients aged
Epidemiology of Childhood Cancers: Challenges and Opportunities Prof Tezer Kutluk MD PhD, FAAP President UICC, Union for International Cancer Control
Epidemiology of Childhood Cancers: Challenges and Opportunities Prof Tezer Kutluk MD PhD, FAAP President UICC, Union for International Cancer Control Moscow, 02 th October 2015 Oncology Hospital Children
Site Specific Coding Rules MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS
Multiple Primary and Histology Site Specific Coding Rules MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways
Peter Gozdyra, MA Jack Williams, PhD, FCES Bruna DiMonte, BScN, RN
Photo by Click Photography Mark L. Greenberg, OC, MB, ChB, FRCPC Mohamed Agha, PhD Jason D. Pole, PhD 20 Peter Gozdyra, MA Jack Williams, PhD, FCES Bruna DiMonte, BScN, RN Atlas of Childhood Cancer in
Chapter 4. Histological groups
Chapter 4. Histological groups D.M. Parkin, J. Ferlay, K. Shanmugaratnam, L. Sobin, L. Teppo and S.L. Whelan In this volume, the main axis of classification is provided by the predominantly site-based
Supplementary Information
Rise in Glioblastoma Multiforme incidence in England 1995 2015 suggests an adverse environmental or lifestyle factor Alasdair Philips, Denis L Henshaw, Graham Lamburn, Michael J O Carroll Supplementary
Characteristics and trends in incidence of childhood cancer in Beijing, China,
Original Article Characteristics and trends in incidence of childhood cancer in Beijing, China, 2000-2009 Lei Yang, Yannan Yuan, Tingting Sun, Huichao Li, Ning Wang Key Laboratory of Carcinogenesis and
Report on Cancer Statistics in Alberta. Childhood Cancer
Report on Cancer Statistics in Alberta Childhood Cancer November 2009 Surveillance - Cancer Bureau Health Promotion, Disease and Injury Prevention Report on Cancer Statistics in Alberta - 2 Purpose of
PEDIATRIC CANCER IN FLORIDA
PEDIATRIC CANCER IN FLORIDA 1981-2 paulo pinheiro jaclyn button lora fleming youjie huang brad wohler jill mackinnon james wilkinson PEDIATRIC CANCER IN FLORIDA 1981-2 Paulo S Pinheiro, MD MSc CTR Jaclyn
Suggested Citation: Copyright Information:
This report was prepared by the CalCARES Program, Institute for Population Health Improvement, UC Davis Health System, for the Chronic Disease Surveillance and Research Branch, California Department of
ANNUAL CANCER REGISTRY REPORT-2005
ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males
Radiation Oncology Study Guide
Radiation Oncology Study Guide For the Initial CertificationQualifying (Computer-Based) Examination General and Radiation Oncology This examination is designed to assess your understanding of the entire
Solid tumors in young children in Moscow Region of Russian Federation
doi:10.2478/v10019-007-0037-2 Solid tumors in young children in Moscow Region of Russian Federation Denis Y Kachanov 1,2, Konstantin V Dobrenkov 2, Tatyana V Shamanskaya 1,2, Ruslan T Abdullaev 1,2, Evgueniya
CODING TUMOUR MORPHOLOGY. Otto Visser
CODING TUMOUR MORPHOLOGY Otto Visser INTRODUCTION The morphology describes the tissue of the tumour closest to normal tissue Well differentiated tumours are closest to normal Undifferentiated tumours show
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 SONGKLANAGARIND HOSPITAL FACULTY OF MEDICINE PRINCE OF SONGKLA UNIVERSITY HATYAI SONGKHLA THAILAND EDITOR PARADEE PRECHAWITTAYAKUL, B.Sc. June, 2013 Songklanagarind
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat version (downloaded 3/23/2017)
APPENDIX I. SEER Search criteria and exclusion criteria. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat version 8.3.4 (downloaded 3/23/2017) SEER*Stat Database:
Classification of spontaneous brain tumors in rats
Classification of spontaneous brain tumors in rats Central Nervous System Neoplasms in the Rat (Solleveld HA, et al., 1991) 1. Tumors of Neuroepithelial Tissue A. Astrocytic and oligodendroglial tumors
Histopathological Study and Categorisation of Brain Tumors
Histopathological Study and Categorisation of Brain Tumors Ruchira Wadhwa 1*, Purvi Patel 2, Hansa Goswami 3 1 Third Year Resident, 2 Assistant Professor, 3 Professor and Head, Department of Pathology,
Survival in Teenagers and Young. Adults with Cancer in the UK
Survival in Teenagers and Young Adults with Cancer in the UK Survival in Teenagers and Young Adults (TYA) with Cancer in the UK A comparative report comparing TYA cancer survival with that of children
Supplementary Table S1 Glossary of preferred terms contained in the malignant or unspecified tumors SMQ narrow basket label (MedDRA version 15.
SUPPLEMENTARY MATERIALS Supplementary Table S1 Glossary of preferred terms contained in the malignant or unspecified tumors SMQ narrow basket label (MedDRA version 15.0) Basket preferred term 5q minus
ICD-O Morphology code. R=Rare Tier Tumour ICD-O Topography code C30.0, C31
R=Rare Tier Tumour ICD-O Topography code ICD-O Morphology code EPITHELIAL TUMOURS OF NASAL CAVITY AND SINUSES R 2 Squamous cell carcinoma with variants of nasal cavity and sinuses C30.0, C3 C30.0, C3 8000,
RESEARCH COMMUNICATION. Childhood Cancer Incidence and Survival , Thailand: Study from the Thai Pediatric Oncology Group
Childhood Cancer Incidence and Survival 2003-2005, Thailand RESEARCH COMMUNICATION Childhood Cancer Incidence and Survival 2003-2005, Thailand: Study from the Thai Pediatric Oncology Group Surapon Wiangnon
Cancer Incidence Rates and Trends Among Children and Adolescents in the United States,
ARTICLE Cancer Incidence Rates and Trends Among Children and Adolescents in the United States, 2001 2009 AUTHORS: David A. Siegel, MD, MPH, a Jessica King, MPH, b Eric Tai, MD, MS, c Natasha Buchanan,
Cancer in Estonia 2014
Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National
S2199 S2200. * Speaker's diagnosis 78
98 21 2 14 13:30 * Speaker's diagnosis 78 S2199 Meningioma 48 Papillary meningioma * 30 Angiomatous meningioma 15 Ependymoma 12 Papillary ependymoma 6 Anaplastic ependymoma 2 Cellular ependymoma 1 Hemangioblastoma
Burden of Cancer in California
Burden of Cancer in California California Cancer Reporting and Epidemiologic Surveillance Institute for Population Health Improvement UC Davis Health August 22, 2018 Outline 1. Incidence and Mortality
2 Berkeley Street, Suite 403, Toronto, Ontario M5A 2W3 Visit us at: Tel: Fax:
E-Path A.I. Engine Knowledge Base Enhancements Version 1.0.0.29 April 1, 2018 The major enhancements in the E-Path Knowledge Base from versions 1.0.0.28 through 1.0.0.29 are as follows: 1. Addition/modification
2018 ICD-O-3 Updates in Table Format with Annotation for Reference
Status Histology Description (this may be preferred term or a synonym) Report Comments New term 8010 3 Urachal carcinoma (C65.9, C66.9, C67._, C68._) New term 8013 3 Combined large cell neuroendocrine
CNS TUMORS. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)
CNS TUMORS D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) CNS TUMORS The annual incidence of intracranial tumors of the CNS ISmore than intraspinal tumors May be Primary or Secondary
Épidémiologie des sarcomes en Belgique
1 Épidémiologie des sarcomes en Belgique Dr. Liesbet Van Eycken 12 es journées annuelles du GSF-GETO Oud Sint-Jan Bruges, 22-24 juin 2016 Overview Introduction Descriptive epidemiology Incidence Age specific
CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017)
CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017) Leukemia AALL0932 closed after Induction Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized
Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018)
Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018) Please refer to your standard setter(s) for specific reporting requirements before using
Pelvic tumor in childhood Classification, imaging approach and radiological findings
Pelvic tumor in childhood Classification, imaging approach and radiological findings M. Mearadji International Foundation for Pediatric Imaging Aid Rotterdam, The Netherlands Solid pelvic masses in childhood
An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea, 2013
ORIGINAL ARTICLE Brain Tumor Res Treat 217;5(1):16-23 / pissn 2288-245 / eissn 2288-2413 https://doi.org/1.14791/btrt.217.5.1.16 An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of
Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific
Effective January 1, 2018 codes, behaviors and terms are site specific /N 8551/3 Acinar adenocarcinoma (C34. _) Lung primaries diagnosed prior to 1/1/2018 use code 8550/3 For prostate (all years) see 8140/3
Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific
Effective January 1, 2018 codes, behaviors and terms are site specific Status /N 8010/3 Urachal carcinoma (C65.9, C66.9, C67. _, C68._) 8013/3 Combined large cell neuroendocrine carcinoma (C34. _, C37.9)
State of Art in Pediatric Cancer. Surapon Wiangnon
State of Art in Pediatric Cancer Surapon Wiangnon Background 68 M Life expectancy 73.6 Male 71.2, Female 76.1 Birth Rate: 12.66/1,000 pop. Death Rate: 7.47/1,000 pop. Infant Mortality Rate: 15.41 deaths/1,000
Suggested Citation: Production and design by Magdalena Burgos.
This report was prepared by the CalCARES Program, Institute for Population Health Improvement, UC Davis Health System, for the Chronic Disease Surveillance and Research Branch, California Department of
CODING PRIMARY SITE. Nadya Dimitrova
CODING PRIMARY SITE Nadya Dimitrova OUTLINE What is coding and why do we need it? ICD-10 and ICD-O ICD-O-3 Topography coding rules ICD-O-3 online WHAT IS CODING AND WHY DO WE NEED IT? Coding: to assign
ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN
ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Ain ul Quader, Hina Asif, Adna Atif, Lubna Nadeem,
Cancer Association of South Africa (CANSA)
Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)
ACR TXIT TM EXAM OUTLINE
ACR TXIT TM EXAM OUTLINE Major Domain Sub-Domain 1 Statistics 1.1 Study design 1.2 Definitions of statistical terms 1.3 General interpretation & analysis 1.4 Survival curves 1.5 Specificity/sensitivity
CANCER REGISTRY 2004
2 National Cancer Institute Department of Medical Services Ministry of Public Health Thailand Edited by Pattarawin Attasara, M.D. ISSN 974-7980-57-6 NATIONAL INSTITUTE STAFFS Consultant : Editor : Office
CANCER IN YOUNG PEOPLE IN CANADA: A REPORT FROM THE ENHANCED CHILDHOOD CANCER SURVEILLANCE SYSTEM
CANCER IN YOUNG PEOPLE IN CANADA: A REPORT FROM THE ENHANCED CHILDHOOD CANCER SURVEILLANCE SYSTEM TO PROMOTE AND PROTECT THE HEALTH OF CANADIANS THROUGH LEADERSHIP, PARTNERSHIP, INNOVATION AND ACTION IN
Childhood Cancer Staging Rules for Population Based Registries
Childhood Cancer Staging Rules for Population Based Registries Based on the Toronto Paediatric Cancer Stage Guidelines 1 Suggested citation Aitken JF, Youlden DR, Ward LJ, Thursfield VJ, Baade PD, Hallahan
ANNUAL CANCER REGISTRY REPORT-2015
CANCER STATISTICS Distribution of neoplasms ANNUAL CANCER REGISTRY REPORT-2015 Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Hina Asif, Adna Atif, Farhana Badar Of a total of 5,924 new neoplasms diagnosed
Epidemiology of Primary Brain and Central Nervous System Tumors in Korea
www.jkns.or.kr 1.334/jkns.21.48.2.145 J Korean Neurosurg Soc 48 : 145-152, 21 Print ISSN 25-3711 On-line ISSN 1598-7876 Copyright 21 The Korean Neurosurgical Society Clinical Article Epidemiology of Primary
Cancer in California:
Cancer in California: 1988-2010 This report was prepared by the Institute for Population Health Improvement, UC Davis Health System, for the Chronic Disease Surveillance and Research Branch, California
Tumors of the Fetus and Infant
Tumors of the Fetus and Infant Hart Isaacs, Jr Tumors of the Fetus and Infant An Atlas Second Edition Hart Isaacs, Jr Department of Pathology Rady Childrens Hospital San Diego University of California
Classification, incidence and survival analyses of children with CNS tumours diagnosed in Sweden
Acta Pædiatrica ISSN 0803 5253 REGULAR ARTICLE Classification, incidence and survival analyses of children with CNS tumours diagnosed in Sweden 1984 2005 Birgitta Lannering 1, Per-Erik Sandström 2, Stefan
21st Century Pediatric Cancer Sourcebook: Childhood Bone Cancer - Osteosarcoma And Malignant Fibrous Histiocytoma (MFH) Of Bone - Clinical Data,
21st Century Pediatric Cancer Sourcebook: Childhood Bone Cancer - Osteosarcoma And Malignant Fibrous Histiocytoma (MFH) Of Bone - Clinical Data, Practical Information For Patients, Physicians [Kindle By
Colombia Médica colombiamedica.univalle.edu.co
Journal homepage: http://colombiamedica.univalle.edu.co Bravo LE et al / Colombia Médica - Vol. 44 Nº 3, 2013 (Jul-Sept) Colombia Médica colombiamedica.univalle.edu.co Colombia Médica Facultad de Salud
WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded
Rare cancers are those with an incidence rate 6/100,000
Rare cancers are those with an incidence rate 6/100,000 Layer Tumour Rate x 100,000 Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES 0.44 3,594 2 Squamous cell carcinoma and variants of the
The European Commission s science and knowledge service. Joint Research Centre
The European Commission s science and knowledge service Joint Research Centre Coding Primary Site and Tumour Morphology JRC-ENCR training course Copenhagen, 25 September 2018 Nadya Dimitrova Outline What
INTRACRANIAL NEOPLASMS IN IBADAN, NIGERIA. B.J. OLASODE, M.T. SHOKUNBI and P.U. AGHADIUNO
4 EAST AFRICAN MEDICAL JOURNAL January 2000 East African Medical Journal Vol. 77 No. 1 January 2000 INTRACRANIAL NEOPLASMS IN IBADAN, NIGERIA B.J. Olasode, MBBCh (Cal), DCP (Lond), FWACP (West Afr.), Department
The Development of Pediatric Oncology in Turkey:
The Development of Pediatric Oncology in Turkey: Improving Childhood Cancer Survival Rate Through Professional Training and Education Prof. Dr. Tezer Kutluk, MD PhD, FAAP UICC president & Hacettepe University
Cancer Among New Zealand Adolescents and Young People An occasional paper
Cancer Among New Zealand Adolescents and Young People 1988 2002 An occasional paper The image on the front cover is Farbstudie Quadrate mit konzentrischen Ringen ( Colour study of squares with concentric
Leukaemia 35% Lymphoma 14%
Distribution ib ti of Cancers in Children under 15 years Leukaemia 35% Lymphoma 14% Neuroblastoma 9% Other 5% Liver 1% Retinoblastoma 3% Bone and STS 15% CNS 20% Wilms' 8% 30-40% Mortality Germ Cell Tumours
Spatial clustering of childhood cancers in Switzerland
Spatial clustering of childhood cancers in Switzerland Garyfallos Konstantinoudis; Christian Kreis; Roland A. Ammann; Felix Niggli; Claudia E. Kuehni; Ben D. Spycher Institute of Social and Preventive
Neuro-Oncology. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in
Neuro-Oncology Neuro-Oncology 17:iv1 iv62, 2015. doi:10.1093/neuonc/nov189 CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 Quinn T.
Checklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005
ChecklistTemplateVersions ChecklistTemplateVersion Ckey OfficialName VisibleText RevisionDate Checklist; Adrenal gland: 16.1000043 Resection Adrenal gland: Checklist; Ampulla of 17.1000043 Vater: Ampullectomy
ANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN
ANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Ain ul Quader, Hina Asif, Adna Atif, Mehwish Waseem,
Patients Treated with Leksell Gamma Knife
Patients Treated with Leksell Gamma Knife 1968-2016 TREATMENTS REPORTED 2016 BY REGION AND INDICATION INDICATION Asia excl. Europe Latin Middle East & Africa North Grand Total Benign Tumors 12283 9778
Childhood cancer survival : Dr. Behçet Uz Children s Hospital registry
Turkish Journal of Cancer Vol.30/ No. 2/2000 Childhood cancer survival 1990-1997: Dr. Behçet Uz Children s Hospital registry ÖZNUR DÜZOVALI 1, RAGIP ORTAÇ 2, İRFAN KARACA 3, NAZİHAT ARGON 4, YASEMİN USLU
CANCER REGISTRY 2002
2 National Cancer Institute Department of Medical Services Ministry of Public Health Thailand Edited by Pattarawin Attasara, M.D. ISSN 974-7980-57-6 NATIONAL INSTITUTE STAFFS Consultant : Editor : Office
WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not
Annual Report 2009/2010
Swiss Childhood Cancer Registry Schweizer Kinderkrebsregister Registre Suisse du Cancer de l'enfant Registro Svizzero dei Tumori Pediatrici Jahresbericht Rapport annuel Relazione annuale Annual Report
155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary
ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant
Module Guide 2017/18
MSc in Oncology Including PG Certificate and PG Diploma Cancer Treatments 2 Module Guide 2017/18 Part B Clinical Sciences Contents Module details 1.1 Module overview... 3 1.2 Module specification... 3
Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths
RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected
swiss childhood cancer registry annual report
swiss childhood cancer registry annual report 2013-2014 Swiss Childhood Cancer Registry Annual Report 2013/2014 For the Swiss Childhood Cancer Registry Matthias Schindler Vera Mitter Verena Pfeiffer Shelagh
Colombia Médica colombiamedica.univalle.edu.co
Journal homepage: http://colombiamedica.univalle.edu.co Colombia Médica colombiamedica.univalle.edu.co Colombia Médica Facultad de Salud Universidad del Valle Original Article Descriptive epidemiology
Overview of 2010 Hong Kong Cancer Statistics
Overview of 2010 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since the 1960s been providing population-based cancer data for epidemiological research
APPENDIX ONE: ICD CODES
APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding
Pathology Mystery and Surprise
Pathology Mystery and Surprise Tim Smith, MD Director Anatomic Pathology Medical University of South Carolina Disclosures No conflicts to declare Some problem cases Kidney tumor Scalp tumor Bladder tumor
The Completeness of Soft Tissue Sarcoma Data in the National Cancer Data Repository
The Completeness of Soft Tissue Sarcoma Data in the National Cancer Data Repository Tumours diagnosed between 2006 and 2008 West Midlands Cancer Intelligence Unit Completeness of cancer data 2008 Soft
Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES Squamous cell carcinoma and variants of the Nasal Cavity
Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES 0.471 3060 2 Squamous cell carcinoma and variants of the Nasal Cavity and Sinuses 0.37 2615 3 Squamous carcinoma 0.24 1708
Other Sites. Table 2 Continued. MPH Rules 11/8/07. NAACCR Webinar Series 1
MPH s 11/8/07 Other s 1 Table 2 Continued Use this two-page table to select combination histology codes. Compare the terms in the diagnosis to the terms in Columns 1 and 2. If the terms match, code the
FINALIZED SEER SINQ QUESTIONS
0076 Source 1: WHO Class CNS Tumors pgs: 33 MP/H Rules/Histology--Brain and CNS: What is the histology code for a tumor originating in the cerebellum and extending into the fourth ventricle described as